Veterinary Medicines

Zoletil 50 Vet. pulver og solvens til injektionsvæske, opløsning 25 + 25 mg/ml

Authorised
  • Zolazepam hydrochloride
  • Tiletamine hydrochloride
Download as PDF

Product identification

Medicine name:
Zoletil 50 Vet. 25 + 25 mg/ml pulver og solvens til injektionsvæske, opløsning
Zoletil 50 Vet. pulver og solvens til injektionsvæske, opløsning 25 + 25 mg/ml
Active substance:
  • Zolazepam hydrochloride
  • Tiletamine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Zolazepam hydrochloride
    141.00
    milligram(s)
    /
    1.00
    Vial
  • Tiletamine hydrochloride
    145.50
    milligram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Powder and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 14169
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, PULVER OG SOLVENS TIL INJEKTIONSVÆSKE, OPLØSNING)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."